Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę "Erglis, Andrejs" wg kryterium: Autor


Wyświetlanie 1-9 z 9
Tytuł:
Patients with coronary artery disease and diabetes need improved management : a report from the EUROASPIRE IV survey : a registry from the EuroObservational Research Programme of the European Society of Cardiology
Autorzy:
Dolzhenko, Maryna
Laucevicius, Aleksandras
Jennings, Catriona
Lovic, Dragan
Pogosova, Nana
Wood, David
Oganov, Raphael
Dilic, Mirza
Vulic, Dusko
De Sutter, Johan
Castro Conde, Almudena
De Bacquer, Guy
Stork, Stefan
Łysek, Radosław
Schnell, Oliver
Erglis, Andrejs
Heuschmann, Peter
Kotseva, Kornelia
Gyberg, Viveca
EUROASPIRE Investigators,
Moore, David
Ryden, Lars
Reiner, Zeljko
Tuomilehto, Jaakko
Lehto, Seppo
Fras, Zlatko
Goudevenos, John
Bruthans, Jan
Wolfshaut-Wolak, Renata
Gaita, Dan
Pająk, Andrzej
Amouyel, Philippe
Tokgozoglu, Lale
Nicolaides, Evagoras
Brzezicka, Elżbieta
Gotcheva, Nina
Deckers, Jaap W.
Mellbin, Linda
Stagmo, Martin
Milicic, Davor
Cifkova, Renata
De Bacquer, Dirk
Misiowiec, Witosława
Opis:
Background In order to influence every day clinical practice professional organisations issue management guidelines. Cross-sectional surveys are used to evaluate the implementation of such guidelines. The present survey investigated screening for glucose perturbations in people with coronary artery disease and compared patients with known and newly detected type 2 diabetes with those without diabetes in terms of their life-style and pharmacological risk factor management in relation to contemporary European guidelines. Methods A total of 6187 patients (18–80 years) with coronary artery disease and known glycaemic status based on a self reported history of diabetes (previously known diabetes) or the results of an oral glucose tolerance test and HbA1c (no diabetes or newly diagnosed diabetes) were investigated in EUROASPIRE IV including patients in 24 European countries 2012–2013. The patients were interviewed and investigated in order to enable a comparison between their actual risk factor control with that recommended in current European management guidelines and the outcome in previously conducted surveys. Results A total of 2846 (46 %) patients had no diabetes, 1158 (19 %) newly diagnosed diabetes and 2183 (35 %) previously known diabetes. The combined use of all four cardioprotective drugs in these groups was 53, 55 and 60 %, respectively. A blood pressure target of <140/90 mmHg was achieved in 68, 61, 54 % and a LDL-cholesterol target of <1.8 mmol/L in 16, 18 and 28 %. Patients with newly diagnosed and previously known diabetes reached an HbA1c <7.0 % (53 mmol/mol) in 95 and 53 % and 11 % of those with previously known diabetes had an HbA1c >9.0 % (>75 mmol/mol). Of the patients with diabetes 69 % reported on low physical activity. The proportion of patients participating in cardiac rehabilitation programmes was low (≈40 %) and only 27 % of those with diabetes had attended diabetes schools. Compared with data from previous surveys the use of cardioprotective drugs had increased and more patients were achieving the risk factor treatment targets. Conclusions Despite advances in patient management there is further potential to improve both the detection and management of patients with diabetes and coronary artery disease.
Dostawca treści:
Repozytorium Uniwersytetu Jagiellońskiego
Artykuł
    Wyświetlanie 1-9 z 9

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies